Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone

PACE - Pacing and Clinical Electrophysiology

Volumn 28, Issue 9, 2005, Pages 954-961

  Fragakis, Nikolaos ^a,b   Papadopoulos, Nikolaos ^a   Papanastasiou, Soultana ^a   Kozirakis, Miltiadis ^a   Maligkos, George ^a   Tsaritsaniotis, Evangelos ^a   Katsaris, George ^a  

^a 2nd Cardiac Department   (Greece)

^b NONE   (Greece)

Author keywords

Amiodarone; Atrial fibrillation; Atrial flutter; Cardioversion; Ibutilide; Propafenone

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; IBUTILIDE; PROPAFENONE; ANTIARRHYTHMIC AGENT; SULFONAMIDE;

ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIOVERSION; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; QT PROLONGATION; SINUS BRADYCARDIA; ANALYSIS OF VARIANCE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DRUG COMBINATION; ELECTROCARDIOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; AMIODARONE; ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROPAFENONE; PROSPECTIVE STUDIES; SULFONAMIDES; TREATMENT OUTCOME;

EID: 33644668141     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2005.00212.x     Document Type: Article

References (31)

1. Stroobandt R, Stiels B, Hoebrechts R, on behalf of the Propafenone Atrial Fibrillation Trial Investigators. Propafenone for conversion and prophylaxis of atrial fibrillation. Am J Cardiol 1997 79 : 418 423.
2. Chevalier P, Durand-Dubief AD, Burri H, et al. Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: A meta-analysis. J Am Coll Cardiol 2003 41 : 255 262.
3. Kochiadakis G, Marketou M, Igoumenidis N, et al. Amiodarone, Sotalol, or propafenone in atrial fibrillation: Which is preferred to maintain normal sinus rhythm? PACE 2000 23 (Pt. II 1883 1887.
4. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995 92 : 1954 1968.
5. Stambler B, Wood M, Ellenbogen K. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996 94 : 1613 1621.
6. Volgman A, Carberry P, Stambler B, et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998 31 : 1414 1419.
7. Vos MA, Golitsyn SR, Stangl K, et al. Superiority of ibutilide over DL-sotalol in converting atrial flutter and atrial fibrillation. Heart 1998 79 : 568 575.
8. Glatter K, Yang Y, Chatterjee K, et al. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy. Circulation 2001 103 : 253 257.
9. Hongo R, Themistoclakis S, Raviele A, et al. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents. J Am Coll Cardiol 2004 44 : 864 868.
10. Chiladakis J, Kalogeropoulos A, Patsouras N, Manolis A. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter. J Am Coll Cardiol 2004 44 : 859 863.
11. Murray KT. Ibutilide: Review. Circulation 1998 97 : 493 497.
12. Hohnloser SH, Klingenheben T, Singh BN, et al. Amiodarone-associated proarrhythmic effects. Ann Intern Med 1994 121 : 529 535.
13. Harrison DC. Antiarrhythmic drug classification: New science and practical applications. Am J Cardiol 1985 56 : 185 187.
14. Reiffel JA, Blitzer M. The actions of ibutilide and class Ic drugs on the slow sodium channel: New insights regarding individual pharmacologic effects elucidated through combination therapies. J Cardiovasc Pharmacol Ther 2000 5 : 177 181.
15. Rensma PL, Allessie MA, Lammers JEP, et al. The length of the excitation wave as an index for the susceptibility to reentrant atrial arrhythmias. Circ Res 1988 62 : 395 410.
16. Feld GK, Venkatesh N, Singh BN. Pharmacologic conversion and suppression of experimental canine atrial flutter: Differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction. Circulation 1986 74 : 197 204.
17. Inoue H, Yamashita T, Nozaki A, Sugimoto T. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: Role of prolongation of refractory period and depression of conduction to excitable gap. J Am Coll Cardiol 1991 18 : 1098 1104.
18. Tai CT, Chen SA, Feng AN, Yu WC, Chen YJ, Chang MS. Electropharmacologic effects of class I and class III antiarrhythmic drugs on typical atrial flutter. Insights into the mechanism of termination. Circulation 1998 97 : 1935 1945.
19. Tai CT, Chen SA. Mechanisms of antiarrhythmic drug action on termination of atrial flutter. PACE 2001 24 : 824 834.
20. Spinelli W, Hoffman BF. Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents. Circ Res 1989 65 : 1565 1579.
21. Buchanan LV, LeMay RJ, Walters RR, et al. Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model. J Cardiovasc Electrophysiol 1996 7 : 113 119.
22. Stambler B, Wood M, Ellenbogen K. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation. Circulation 1997 96 : 4298 4306.
23. Cheng J, Glatter K, Yang Y, Zhang S, Lee R, Scheinman M. Electrophysiological response of the right atrium to ibutilide during typical atrial flutter. Circulation 2002 106 : 814 819.
24. Lee KS. Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+current in guinea pig ventricular cells. J Pharmacol Exp Ther 1992 262 : 99 108.
25. Castro A, Bianconi L, Santini M. New antiarrhythmic drugs for the treatment of atrial fibrillation. PACE 2002 25 : 249 257.
26. Ellenbogen KA, Stambler BS, Wood MA, et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose response study. J Am Coll Cardiol 1996 28 : 130 136.
27. Gill J, Heel RC, Fitton A. Amiodarone: An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias. Drugs 1992 43 : 69 110.
28. Sicouri S, Moro S, Litovsky S, et al. Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart. J Cardiovasc Electrophysiol 1997 8 : 1269 1279.
29. Sticherling C, Hsu W, Tada H, et al. Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation atrial refractoriness. J Cardiovasc Electrophysiol 2002 13 : 151 157.
30. Oral H, Özaydin M, Tada H, et al. Comparison of amiodarone versus ibutilide for the prevention of immediate recurrences of atrial fibrillation during pulmonary vein isolation. Am J Cardiol 2002 90 : 492 495.
31. Van Noord T, Van Gelder I, Crijns H. How to enhance acute outcome of electrical cardioversion by drug therapy: Importance of immediate reinitiation of atrial fibrillation. J Cardiovasc Electrophysiol 2002 13 : 822 825.